tirzepatide lean‑body‑mass
Semaglutide Beats Tirzepatide The Muscle Loss Myth Exposed
Women on tirzepatide lost 6.1 kg of lean mass over 12 months - about twice the loss seen in men and double the loss reported for semaglutide users, according to wearable digital phenotyping data. This finding highlights a silent muscle-loss risk in routine obesity care that has been under-appreciated